Respiratory syncytial virus (RSV) can affect almost anyone of any age, showing itself like a bad cold in adults and older children. But in younger children, particularly infants, it can become something much worse.
Very many lives may someday depend on the work of researchers like Tony Kim. He’s fighting atherosclerosis, the foremost cause of coronary artery disease, which is America’s single greatest killer.
A new five-year grant from the National Institutes of Health (NIH) will help the Georgia Institute of Technology train the next generation of leaders in ImmunoEngineering – a new wave of researchers applying the tools and principles of engineering to study the immune system in health and disease
The National Institutes of Health (NIH) has awarded Lena Ting, professor in the Wallace H. Coulter Department of Biomedical Engineering at Emory and Georgia Tech, a five year, $2.6 million grant.
For the past 13 years, Sally Gerrish has been organizing the Biotech Career Fair at the Georgia Institute of Technology. It’s one of the signature events for the Wallace H. Coulter Department of Biomedical Engineering, coming as it does during a busy season of recruitment for companies.
Thirty years ago, long before there was a Petit Institute for Bioengineering and Bioscience, biomedical research in Georgia experienced a big bang with establishment of the Emory/Georgia Tech Biomedical Technology Research Center and a seed grant program that nurtured faculty interest in collabor
The Wallace H. Coulter Foundation awarded $850,000 in total seed money to support five new biomedical research projects from Emory University and Georgia Tech with the goal of accelerating the translation of these technological innovations.
After a decade of research collaboration, the Atlanta Clinical & Translational Science Institute (ACTSI) will welcome a new partner and change its name, reflecting a new statewide focus.
The National Cancer Institute (NCI) has awarded Melissa Kemp, associate professor in the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory, and a multidisciplinary team of researchers a five year, $3.2 million grant.
The Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory is again ranked No.1 in U.S.
Emory University has appointed Vikas P. Sukhatme, MD, ScD, a distinguished physician-scientist, as the new Dean of Emory University School of Medicine.
The National Science Foundation (NSF) has awarded nearly $20 million to a consortium of universities to support a new engineering research center (ERC) that will work closely with industry and clinical partners to develop transformative tools and technologies for the consistent, scalable and low-
C. Ross Ethier, professor in the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory, and a researcher in the Petit Institute for Bioengineering and Bioscience, was inducted into the Biomedical Engineering Society’s 2017 Class of BMES Fellows.
Medical robotics has been instrumental in revolutionizing medical diagnosis and therapy for the past few decades. However, there are significant gaps in healthcare delivery for both adult and pediatric populations.
By Manasi Deshpande
The Master in Biomedical Innovation and Development (MBID) program was created in 2013 by the Wallace H.
A few weeks at the Georgia Institute of Technology may have clarified Elizabeth Martin’s long-range plans, but she’ll have to fulfill her military commitment first.
The National Institute of Allergy and Infectious Diseases has awarded Emory and Georgia Tech investigators a $2.4 million, five-year grant to study non-invasive imaging to detect immune rejection of transplanted organs.
On May 22, Susan Margulies was named the Wallace H. Coulter Chair of the Coulter Department of Biomedical Engineering (BME) at Georgia Tech and Emory University, and a Georgia Research Alliance Eminent Scholar in Injury Biomechanics. She is the fourth chair in the department’s history.
Using tiny snippets of DNA as “barcodes,” researchers have developed a new technique for rapidly screening nanoparticles for their ability to selectively deliver therapeutic genes to specific organs of the body.